Reduction in C. difficile rates using hydrogen peroxide vapor technology

Published on 1st March 2013

A recently published  retrospective, quasi-experimental study from Manian et al. shows the impact of hydrogen peroxide vapor (HPV) technology on C. difficile-associated diarrhea.

Read more

New environmental protection system combats urban terrorism threat

Published on 18th February 2013

Threats against civilian and private security vehicles using airborne contaminants, such as car-jacking and kidnap attempts, can now be protected against following the launch of the new Bioquell LEAF system. 

Read more

Johns Hopkins Study shows HPV Technology Reduces Patient Risk of Superbug Infection

Published on 31st December 2012

A new study conducted by infection control experts at Johns Hopkins Hospital demonstrates that patients admitted to hospital rooms decontaminated using Bioquell hydrogen peroxide vapor technology, rather than standard cleaning protocols, were significantly less likely to acquire multidrug-resistant organisms (MDROs), or so-called hospital superbugs. The study is published in the January issue of Clinical Infectious Diseases.

Read more

Burns units combat superbug outbreaks with HPV disinfection bundle.

Published on 20th August 2012

In the fight against superbug outbreaks, the use of a bundle of infection control measures, including the use of hydrogen peroxide vapor (HPV) technology, have significantly reduced the incidence of nosocomial MRSA and Acinetobactor baumannii in one of Europe's leading burns units.

Read more

HPV shows UV the light for room biodecontamination

Published on 13th April 2012

Latest comparative research shows that hydrogen peroxide vapor (HPV) technology is more effective at reducing bacterial contamination in hospitals than ultraviolet light-based (UVC) systems.

The head-to-head study published in Infection Control and Hospital Epidemiology, was conducted by leading infection control practitioners at the Hospital of Saint Raphael and Yale University School of Medicine, both in New Haven, Connecticut.  Their results showed that Bioquell’s HPV was significantly more effective for reducing biological contamination, including spores, in patient rooms compared with a UVC system. This was especially evident for areas that were out of direct line of sight of the UVC system.  Overall, half of the surfaces contaminated with bacteria before exposure to UVC remained contaminated after UVC exposure. 

Read more

Bioquell Bug Stoppers raise awareness in the fight against HAIs

Published on 7th March 2012

In the United States, healthcare associated infections (HAIs) and their cost to the healthcare system are staggering.  The CDC estimates that approximately 1 in every 20 hospitalized patients will contract an HAI.  Cost estimates range upward of $40 billion dollars annually in the fight against HAIs.  Recently released CDC statistics show infection rates and deaths from HAIs climbing.  Deaths attributed with Clostridium difficile infection rates alone have jumped to a range of 14,000 per year.  To help in the fight against HAIs, Bioquell has launched its educational Bug Stoppers campaign.

Read more

HPV room disinfection faster and safer than aHP

Published on 5th March 2012

A recent independent study confirms hydrogen peroxide vapor technology as superior to the aerosolized hydrogen peroxide process. A team at St. George’s Hospital, London, UK, unquestionably established that hydrogen peroxide vapor (HPV) technology from Bioquell is faster, safer, and more effective for room biodecontamination than aerosolized hydrogen peroxide (aHP).

Read more

C-Tick Approval for HPV 'Superbug Busting' Techology

Published on 7th February 2012

The latest generation hydrogen peroxide bio-decontamination technology from Bioquell has now achieved Australian C-Tick approval.  The C-Tick mark provides assurance that products have been tested to the appropriate standards for conformity to the EMC (Electro Magnetic Compatibility) and Radio Telecommunications standards by a registered testing laboratory.

Read more

Award of development contract by General Dynamics as part of new SV vehicle

Published on 18th January 2012

Bioquell announces that it has been awarded a £1.2 million development contract relating to the new vehicle being developed by General Dynamics UK for the UK Ministry of Defense. 

Read more

Bioquell Z-2 now with Yokogawa compatibility

Published on 4th January 2012

Cutting edge bio-decontamination technology now interfaces with market leading data logging system to provide robust and secure information capture for the life science and pharmaceutical markets.

Read more